Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Resolution. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112479876A reveals a novel chiral resolution route for oxazepine intermediates, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Discover the advanced chemical synthesis of epidaunorubicin intermediates via patent CN109293613B. Offers superior purity and supply stability over fermentation methods.
Patent CN103820416B reveals high-stereoselectivity ester hydrolase for chiral synthesis. Enhances purity and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN102603592B reveals a novel DBTA resolution method for chiral aminopyrrolidines, offering high yield and optical purity for pharmaceutical supply chains.
Novel patent CN102757431B details cost-effective Sitagliptin synthesis. Enhances supply chain reliability and reduces manufacturing complexity for global buyers.
Patent CN112020498B details a scalable Brivaracetam intermediate route eliminating chromatography. This offers significant cost reduction and supply chain reliability for API manufacturing.
Patent CN103333111A reveals a low-cost synthesis for Lorcaserin HCl. Discover how this novel route reduces production cycles and enhances supply chain reliability for obesity drug intermediates.
Novel process for (1S)-4,5-dimethoxy-1-(methylaminomethyl)-benzocyclobutane synthesis offering superior yield and purity for reliable API intermediate supply chains.
Patent CN114014874A reveals a cyclic resolution method for Baloxavir intermediates, significantly reducing waste and improving yield for reliable pharmaceutical intermediate supply chains.
Patent CN111194304A details an enzymatic method for high-purity bridged ring intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN101270112A details a polymeric Schiff base-metal complex for high-ee cyclic carbonates, offering superior recyclability and cost efficiency for pharma intermediates.
Novel 8-step synthesis of 5-fluoro-3-methylisobenzofuranone from phthalimide. High yield, low cost route for Laratinib intermediate suitable for commercial scale-up.
Novel method for (R)/(S)-6,6'-dihydroxy-5,5'-bisquinoline using CuCl2 oxidation and crystallization resolution, offering high purity and scalable production for pharma intermediates.
Advanced Salen-catalyzed kinetic resolution process for high-purity statin intermediates. Delivers cost reduction in API manufacturing and reliable supply chain continuity.
Patent CN111187255B reveals a mild, high-purity synthesis route for D-ilaprazole. Discover cost-effective manufacturing and supply chain advantages for API intermediates.
Patent CN115611811B reveals chiral ionic liquid technology for high-purity L-Threonine resolution offering significant supply chain and cost advantages.
Patent CN111233931B details a novel Remdesivir synthesis using Lewis acid catalysis. Discover cost-effective, scalable manufacturing solutions for high-purity antiviral intermediates.
Patent CN101735085A details a high-yield D-serine synthesis using dynamic kinetic resolution, offering significant cost reduction and supply stability for pharmaceutical intermediates.
Discover advanced processes for preparing cyclopenta[d]pyrimidin-4-yl piperazine compounds. Enhance supply chain reliability and reduce manufacturing costs for AKT inhibitors.
Patent CN109912624A reveals a streamlined synthetic route for Baloxavir marboxil intermediates, offering significant supply chain reliability and cost advantages for pharmaceutical manufacturers.